Comment on: Paradoxically protective effect of glucocorticoids on bone mass and fragility fracture in a large cohort: a cross-sectional study

Rheumatol Adv Pract. 2022 Feb 17;6(2):rkac010. doi: 10.1093/rap/rkac010. eCollection 2022.

Kaleen N Hayes¹, Andrea M Burden², Elizabeth M Winter³, Barbara Hauser^{4

5}

¹ Department of Health Services, Policy and Practice, Brown University School of Public Health, Providence, RI, USA.
² Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, Switzerland.
³ Center for Bone Quality, Division of Endocrinology, Department of Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands.
⁴ Rheumatic Disease Unit, Western General Hospital, NHS Lothian.
⁵ Rheumatology and Bone Disease Unit, Centre for Genomic and Experimental Medicine Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.

No abstract available